Results 11 to 20 of about 4,857 (187)

Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS

HIV/AIDS: Research and Palliative Care, 2016
Melissa E Badowski,1 Sarah E Perez2 1Department of Pharmacy Practice, Section of Infectious Diseases Pharmacotherapy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA; 2Infectious Diseases Clinic, Tufts Medical Center, Boston, MA,
Badowski ME, Perez SE
doaj   +4 more sources

Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder. [PDF]

Schizophr Bull
Brunette MF, Roth RM, Trask C, Khokhar JY, Ford JC, Park SH, Hickey SM, Zeffiro T, Xie H.   +8 more
europepmc   +3 more sources

Therapeutic Potential of Dronabinol: A Systematic Review of Human Trials [PDF]

Farmacja Polska, 2021
Dronabinol is an isomer of tetrahydrocannabinol that seems to have potential for both somatic and psychiatric disorders treatment. The purpose of this review is to provide an overview of collected articles with emphasis on the efficacy and safety of ...
Julia Lewandowska, Jan Maciej Kapała, Łukasz Puchała   +2 more
doaj   +1 more source

Pronounced State-Level Disparities in Prescription of Cannabinoids to Medicaid Patients

Medical Cannabis and Cannabinoids, 2023
Introduction: Dronabinol is approved in the USA for chemotherapy-induced nausea as well as vomiting and HIV-induced anorexia, while cannabidiol is primarily approved for childhood epileptic disorders Lennox-Gastaut and Dravet syndrome.
Edward Y. Liu, Kenneth L. McCall, Brian J. Piper   +2 more
doaj   +1 more source

DMSO potentiates the suppressive effect of dronabinol on sleep apnea and REM sleep in rats

Journal of Cannabis Research, 2023
Introduction Dimethyl sulfoxide (DMSO) is an amphipathic molecule with innate biological activity that also is used to dissolve both polar and nonpolar compounds in preclinical and clinical studies.
Michael W. Calik, David W. Carley
doaj   +1 more source

Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury

Trauma Surgery & Acute Care Open, 2020
Background To determine whether adjunctive dronabinol, a licensed form of delta-9-tetrahydrocannabinol, reduces opioid consumption when used off-label for managing acute pain following traumatic injury.Methods This matched cohort study included patients ...
Kristin Salottolo, Robert M Madayag, David Bar-Or, Elisabeth Schneider-Smith, Claire Swartwood, Casey Melvin   +5 more
doaj   +1 more source

The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials

Pharmaceuticals, 2022
Dronabinol, a natural cannabinoid, and its semi-synthetic derivative, nabilone, are marketed as medicines in several countries. The aim of our work was to systematically evaluate the frequency of adverse events related to dronabinol or nabilone treatment
Ákos Bajtel, Tivadar Kiss, Barbara Tóth, Szabolcs Kiss, Péter Hegyi, Nóra Vörhendi, Boglárka Csupor-Löffler, Noémi Gede, Judit Hohmann, Dezső Csupor   +9 more
doaj   +1 more source

Cannabinoids for Medical Purposes in Children: A Living Systematic Review. [PDF]

Acta Paediatr
ABSTRACT Aim We developed a living systematic review (LSR) that will continuously map the safety and reported benefit data related to cannabinoid use for medical purposes in children. Methods MEDLINE, Embase, PsycInfo, and the Cochrane Library were searched from inception to April 2023.
Chhabra M, Paul A, Abulannaz O, Lê ML, Mansell H, Finkelstein Y, Huntsman RJ, Kelly LE.   +7 more
europepmc   +2 more sources

Efficacy of Dronabinol for Acute Pain Management in Adults with Traumatic Injury: Study Protocol of A Randomized Controlled Trial

Brain Sciences, 2020
Delta-9-tetrahydrocannabinol (Δ9-THC) and other cannabinoids present in cannabis (marijuana) have been shown to affect the normal inhibitory pathways that influence nociception in humans.
Claire Swartwood, Kristin Salottolo, Robert Madayag, David Bar-Or   +3 more
doaj   +1 more source

Caracterización de la problemática del uso terapéutico del Aceite de Cannabis en Córdoba, Argentina

Revista de la Facultad de Ciencias Médicas de Córdoba, 2022
El uso terapéutico del aceite de “cannabis” es una problemática social que pone en tensión aspectos legales, sanitarios, científicos y culturales. La dificultad en el acceso genera un vacío aprovechado por el mercado ilegal, al que recurren pacientes y ...
Pablo Gabriel Manzo, Sandra Martín, Sonia Uema, Germán Charles, Felipe Montero Bruni, Susana Núñez Montoya, María Eugenia Bertotto , Martín Eynard , Pedro Armando, Carolina Bustos Fierro   +9 more
doaj   +1 more source